In recent years, cancer research has witnessed groundbreaking innovations that have transformed diagnostics and treatment. Central to this progress is the advent of artificial intelligence (AI), which is increasingly being integrated into oncological practices. Among the latest advancements is an
Picture the intricacies hidden within the cell—each nucleus containing a vast genome map, intricately folded into a complex three-dimensional (3D) shape. How does this hidden architecture influence the very essence of life, determining which genes are silent or expressed? The Importance of 3D DNA
The field of cancer treatment is witnessing seismic shifts as MiNK Therapeutics, a clinical-stage biotechnology firm and subsidiary of Agenus Inc., introduces groundbreaking cell-based therapies focused on treating challenging cancers. With its pioneering work on invariant natural killer T (iNKT)
In the dynamic world of biopharma, few individuals possess as vast an understanding of technology and innovation in the field as Ivan Kairatov. With a solid background in research and development, Ivan offers invaluable insights into the recent advancements and decisions impacting the
The rapid evolution of personalized cancer vaccines promises a transformative era in oncology, as evidenced by the latest research on NeoVaxMI conducted by the Dana-Farber Cancer Institute. This study, focused on patients with untreated advanced or high-risk melanoma, explores advancements in the
Introducing Ivan Kairatov, a renowned Biopharma expert with an extensive background in technology, innovation, and research and development within the pharma industry. Ivan is here to discuss the recent European Commission approval of Tevimbra for nasopharyngeal cancer, a significant milestone in
